Main When FDA determines that an advisory committee member has a financial conflict of interest, the agency may grant a waiver that allows the member to participate in an advisory committee meeting if certain criteria and policies are met. In general, FDA may grant a waiver if the member's expertise is considered essential to the committee’s discussions and recommendations. FDA must also take into consideration a cap on the number of waivers that can be granted each year. FDA searches for experts who have the necessary expertise without conflicts of interest; yet, in some cases, many of the top authorities in specialized scientific fields may have a conflict of interest. When FDA grants a waiver, the financial interests associated with the waiver are posted on FDA’s website along with the reasons for granting the waiver. <i>Information is current as of December 31, 2012.</i> Percent Granted Waivers line 0 0 FY 2010 Target: Less than 13.04%

FY 2010 Overall: 1%

Oct 2009 13.04 4 Nov 2009 13.04 2 Dec 2009 13.04 1 Jan 2010 13.04 0 Feb 2010 13.04 0 Mar 2010 13.04 2 Apr 2010 13.04 0 May 2010 13.04 1 Jun 2010 13.04 0 Jul 2010 13.04 1 Aug 2010 13.04 0 Sep 2010 13.04 0 0 FY 2011 Target: Less than 12.3%

FY 2011 Overall: 1%

Oct 2010 12.3 0 Nov 2010 12.3 1 Dec 2010 12.3 1 Jan 2011 12.3 0 Feb 2011 12.3 0 Mar 2011 12.3 1 Apr 2011 12.3 0 May 2011 12.3 0 Jun 2011 12.3 1 Jul 2011 12.3 4 Aug 2011 12.3 1 Sep 2011 12.3 0 0 FY 2012 Target: Less than 11.5%

FY 2012 Overall: 1%

Oct 2011 11.5 0 Nov 2011 11.5 0 Dec 2011 11.5 0 Jan 2012 11.5 0 Feb 2012 11.5 0 Mar 2012 11.5 7 Apr 2012 11.5 0 May 2012 11.5 2 Jun 2012 11.5 1 Jul 2012 11.5 0 Aug 2012 11.5 0 Sep 2012 11.5 0

FY 2013 YTD: 0.32%

Oct 2012 0 Nov 2012 .88 Dec 2012 0 Jan 2013 Feb 2013 Mar 2013 Apr 2013 May 2013 Jun 2013 Jul 2013 Aug 2013 Sep 2013 Sub Percent of advisory committee members participating in meetings in the month who were granted waivers Waivers Granted line 0 0 200

FY 2010 Total: 14

Oct 2009 4 Nov 2009 3 Dec 2009 1 Jan 2010 0 Feb 2010 0 Mar 2010 4 Apr 2010 0 May 2010 1 Jun 2010 0 Jul 2010 1 Aug 2010 0 Sep 2010 0 0 200

FY 2011 Total: 11

Oct 2010 0 Nov 2010 2 Dec 2010 1 Jan 2011 0 Feb 2011 0 Mar 2011 2 Apr 2011 0 May 2011 0 Jun 2011 1 Jul 2011 4 Aug 2011 1 Sep 2011 0 0

FY 2012 Total: 14

Oct 2011 0 Nov 2011 0 Dec 2011 0 Jan 2012 0 Feb 2012 0 Mar 2012 9 Apr 2012 0 May 2012 4 Jun 2012 1 Jul 2012 0 Aug 2012 0 Sep 2012 0

FY 2013 YTD:1

Oct 2012 0 Nov 2012 1 Dec 2012 0 Jan 2013 Feb 2013 Mar 2013 Apr 2013 May 2013 Jun 2013 Jul 2013 Aug 2013 Sep 2013 Sub Percent of advisory committee members participating in meetings in the month who were granted waivers Committee Members line 0 0 200

FY 2010 Total: 1,323

Oct 2009 111 Nov 2009 131 Dec 2009 192 Jan 2010 32 Feb 2010 55 Mar 2010 190 Apr 2010 96 May 2010 94 Jun 2010 81 Jul 2010 163 Aug 2010 63 Sep 2010 115 0 200

FY 2011 Total: 1,364

Oct 2010 87 Nov 2010 197 Dec 2010 154 Jan 2011 88 Feb 2011 53 Mar 2011 150 Apr 2011 96 May 2011 157 Jun 2011 71 Jul 2011 108 Aug 2011 75 Sep 2011 128 0

FY 2012 Total: 1,328

Oct 2011 54 Nov 2011 178 Dec 2011 153 Jan 2012 82 Feb 2012 140 Mar 2012 137 Apr 2012 94 May 2012 195 Jun 2012 94 Jul 2012 46 Aug 2012 33 Sep 2012 122

FY 2013 YTD: 312

Oct 2012 83 Nov 2012 114 Dec 2012 115 Jan 2013 Feb 2013 Mar 2013 Apr 2013 May 2013 Jun 2013 Jul 2013 Aug 2013 Sep 2013 http://www.fda.gov/AboutFDA/Transparency/track/ucm216403.htm FDA-TRACK Advisory Committees Dashboard ਍††਍਍਍਍਍਍਍